focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.05
Bid: 2.00
Ask: 2.10
Change: 0.15 (7.89%)
Spread: 0.10 (5.00%)
Open: 2.10
High: 2.15
Low: 2.05
Prev. Close: 1.90
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Oct 2021 12:23

RNS Number : 5525P
ValiRx PLC
19 October 2021
 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

ValiRx PLC

 

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Adam Hargreaves

City and country of registered office (if applicable)

Cheshire, UK

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

18/10/2021

6. Date on which issuer notified (DD/MM/YYYY):

19/10/2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

3.94%

4.21%

8.15%

5,302,452

Position of previous notification (if

applicable)

3.89%

3.78%

7.67%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BLH13C52

2,562,580

3.94%

GB00BLH13C52

2,739,872

4.21%

SUBTOTAL 8. A

5,302,452

8.15%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Hargreaves Lansdown (Direct Holding)

3.94%

8.15%

PathCelerate Ltd. (Indirect Holding)

4.21%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

London, UK

Date of completion

19/10/2021

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUKUARAAURAAA
Date   Source Headline
22nd Dec 200912:19 pmRNSRegional Funding
11th Dec 20097:42 amRNS?3m Equity Purchase Agreement
4th Dec 200910:14 amRNSNotice of General Meeting
25th Nov 20097:00 amRNSTrading Update
28th Sep 20097:40 amRNSHalf Yearly Report
14th Sep 20097:00 amRNSNew Distribution Venture & Trading Platform Launch
29th Jul 20098:06 amRNSAustralian Patent Acceptance
3rd Jul 200910:57 amRNSResult of AGM
10th Jun 20091:35 pmRNSFinal Results
10th Jun 20098:50 amRNSAward for cancer therapeutics project
29th May 20097:00 amRNSPlacing Summary and Total Voting Rights
11th May 20097:00 amRNSIssue of Equity
5th May 20091:00 pmRNSIssue of Equity
30th Apr 20097:00 amRNSTotal Voting Rights
27th Apr 20097:00 amRNSIssue of Equity
16th Apr 20093:05 pmRNSHolding(s) in Company
16th Apr 20097:00 amRNSIssue of Equity
9th Apr 20097:00 amRNSIssue of Equity
6th Apr 20099:59 amRNSHolding(s) in Company
31st Mar 20097:00 amRNSUpdate to the Sale of Shares Agreement
31st Mar 20097:00 amRNSIssue of Equity and Directors' Shareholdings
12th Mar 20097:00 amRNSValiRx Announces Promising In Vivo Data
27th Feb 20097:00 amRNSTotal Voting Rights
13th Feb 200910:52 amRNSResult of EGM
30th Jan 20097:00 amRNSTotal Voting Rights
29th Jan 200912:07 pmRNSAvailability of circular
28th Jan 200911:55 amRNSProposed Reorganisation and General Meeting
5th Jan 20092:50 pmRNSIssue of Equity
31st Dec 20089:00 amRNSTotal Voting Rights
15th Dec 20087:00 amRNSGlobal Distribution Agreement
5th Dec 20082:00 pmRNSChange of Adviser
27th Nov 20084:19 pmRNSIssue of Equity
16th Sep 20087:00 amRNSUpdate on cancer detection test
11th Sep 20087:00 amRNSInterim Results
10th Sep 200810:33 amRNSNotice of Results
18th Aug 20084:02 pmRNSAppointment of director
31st Jul 20087:00 amRNSTotal Voting Rights
28th Jul 20082:48 pmRNSAGM Statement
23rd Jul 20084:02 pmRNSDirector's Dealing
14th Jul 20082:23 pmRNSDirector/PDMR Shareholding
14th Jul 20087:00 amRNSValiRx acquires Cronos Therap
9th Jul 20087:00 amRNSValiRx Acquires Global Rights
30th Jun 20084:38 pmRNSJoint Broker Appointment
30th Jun 20087:00 amRNSFinal Results
26th Jun 20087:00 amRNSTherapeutic Pipeline - in viv
23rd Jun 20088:00 amRNSNotice of Results
5th Jun 20089:13 amRNSHolding(s) in Company
30th May 20087:00 amRNSTotal Voting Rights
15th May 200812:37 pmRNSHolding(s) in Company
12th May 20084:42 pmPRNStatement re Placing of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.